U.S. Markets open in 4 hrs 29 mins

DIAGNOS Inc. (ADK.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.5700+0.0100 (+1.79%)
At close: 3:59PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5600
Open0.5600
Bid0.5600 x 0
Ask0.5700 x 0
Day's Range0.5600 - 0.5700
52 Week Range0.1400 - 0.7700
Volume37,430
Avg. Volume103,185
Market Cap38.363M
Beta (5Y Monthly)0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.0330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.95
  • DIAGNOS Announces a Pilot with Opticalia in Spain
    GlobeNewswire

    DIAGNOS Announces a Pilot with Opticalia in Spain

    BROSSARD, Quebec, July 28, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, announces today the signing of a pilot in Spain with three franchisees from Opticalia Group. “A proposal that combines optometrist knowledge, telemedicine and artificial intelligence to obtain fast results, without invasive methodology and with totally reliable results. A smart retinography is also used

  • DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia
    GlobeNewswire

    DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia

    Magrabi Hospital Magrabi Hospitals launches initiative for early screening for diabetic retinopathy BROSSARD, Quebec, July 22, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital. Dr. Ibrahim Al-Omar, Undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the ear

  • DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE
    GlobeNewswire

    DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE

    BROSSARD, Quebec, July 20, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in the early detection of stroke th